A pivotal discovery highlighted the overexpression of CENP-E in serous ovarian cancer, underscoring its relevance in tumorigenesis and bolstering the rationale for targeting CENP proteins in cancer therapy [9]. The gene discussed is CENPE; the disease is ovarian serous adenocarcinoma.